CVS Health released a statement shortly after HB1150 was signed in Arkansas, prohibiting pharmacy benefit managers from ...

A panelist discusses how preserving beta-cell function in type 1 diabetes (T1D) requires a multifaceted approach combining timely diagnosis, immunomodulatory therapies, optimal glycemic control and ...

Shawn Gremminger, president and CEO of the National Alliance of Healthcare Purchaser Coalitions, has joined. The National ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

In 2024, top issues included daily work activities, work-life balance and conflict with managers. Now in 2025, those concerns ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

In a recent conversation with Managed Healthcare Executive, Geoffrey Rutledge, M.D., of HealthTap, warned that the narrative around GLP-1 drugs is often oversimplified—and potentially harmful.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

In a recent discussion with Managed Healthcare Executive, three leading dermatologists and itch experts—Shawn Kwatra, M.D., ...

The analysis from the Urban Institute breaks down projected coverage losses across the 40 Medicaid expansion states, where ...

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...

Women who undergo menopause before the age of 40 are more likely to experience cognitive decline, which may lead to dementia, ...